|genotype 2b with high viral load
Jan 19, 2002
What are my chances of becoming undetectable. I am genotype 2b with a viral load of 4 million. I have no fibrosis. I am being treated with pegintron and the ribavirin, supposedly for 6 months if I am undetectable at 3 months.Should I ask to be treated for a year?
| Response from Dr. Rodriguez-Torres
You have an excellent chance of cure with the early response at week 12.The duration of therapy for 24 weeks vs.48 weeks has not been reported yet in large trials, with Peg-Intron or Pegasys ,plus RBV.There is some data that suggest that longer duration decreases relapses, even in prior non responders.I would say that most probably 24 weeks will be enough,but you should discuss with your physician the later data,and see if there is a documented benefit of longer duration in the next months.In the absence of large studies,it will depend in how you tolerate the drug,side effects,and mostly if you prefer to err on the side of agressive vs.conservative.Still, if you relapse after 24 weeks,you can have a trial with Pegasys-RBV,for 48 weeks.Good luck!
Get Email Notifications When This Forum Updates or Subscribe With RSS
- Itchy Testicles After Anal Fingering Sign Of HIV AIDS
- Jock Itch After Anal Sex Sign Of HIV AIDS
- Sore On Mouth After Getting Scratched Worried I Have HIV
- Are Red Bumps All Over The Body A Sign Of An Std?
- Does Abnormal Vaginal Bleeding Mean I Have An Std?
- How Do I Cure Painful Spots On My Penis?
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.